Allogenic bone marrow transplantation for adults with primary myelodysplastic syndrome (MDS): Evaluation of prognostic factors

被引：0
|
作者：
Fung, HC
Shepherd, JD
Nantel, SH
Horsman, DE
Le, A
Forrest, DE
Toze, CL
Sutherland, HJ
Klingemann, HG
Hogge, DE
Barnett, MJ
机构：
[1] VANCOUVER HOSP & HLTH SCI CTR,BC CANC AGCY,DIV HEMATOL & LAB MED,LEUKEMIA BMT PROGRAM BC,VANCOUVER,BC V5Z 1M9,CANADA
[2] UNIV BRITISH COLUMBIA,VANCOUVER,BC V5Z 1M9,CANADA
来源：
BLOOD | 1996年 / 88卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1909 / 1909
页数：1
相关论文
共 50 条
  • [31] ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: RESULTS OF THE LATIN AMERICAN BONE MARROW TRANSPLANT REGISTRY IN MYELODYSPLASTIC SYNDROME (MDS)
    Duarte, Fernando Barroso
    de Jesus Santos, Talyta Ellen
    Gadelha Moura, Anna Thawanny
    Funke, Vaneuza
    Rensi Colturato, Vergilio Antonio
    Hamerschlak, Nelson
    Villela, Neysimelia Costa
    Lopes, Luis Fernando
    Martins de Almeida Macedo, Maria Cristina
    Vigorito, Afonso Celso
    de Almeida Soares, Rodolfo Daniel
    Paz, Alessandra
    Stevenazzi, Mariana
    Diaz, Lilian
    Halack-Neto, Abraao Elias
    Bettarello, Gustavo
    Gusmao, Breno Moreno
    Salvino, Marco Aurelio
    Calixto, Rodolfo
    Rodrigues Moreira, Maria Claudia
    Goncalves Lemes, Romelia Pinheiro
    BONE MARROW TRANSPLANTATION, 2018, 53 : 661 - 662
  • [32] Unrelated donor marrow transplantation for myelodysplastic syndromes (MDS).
    CastroMalaspina, H
    Collins, JER
    Gajewski, J
    Harris, R
    Ramsay, N
    Deeg, HJ
    BLOOD, 1997, 90 (10) : 465 - 465
  • [33] Allogenic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: A report from the European Working Group on Myelodysplastic Syndrome in Childhood
    Locatelli, F
    Niemeyer, C
    Angelucci, E
    BenderGotze, C
    Burdach, S
    Ebell, W
    Friedrich, W
    Hasle, H
    Hermann, J
    Jacobsen, N
    Klingebiel, T
    Kremens, B
    Mann, G
    Pession, A
    Peters, C
    Schmid, HJ
    Stary, J
    Suttorp, M
    Uderzo, C
    vantVeerKorthof, ET
    Vossen, J
    Zecca, M
    Zimmermann, M
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) : 566 - 573
  • [34] Comparison of Peripheral Blood and Bone Marrow Molecular Profiling in Primary Myelodysplastic Syndromes (MDS)
    Mohamedali, Azim M.
    Gaken, Joop
    Ahmed, Momin
    Kulasekararaj, Austin
    Smith, Alexander E.
    Malik, Farook
    Mufti, Ghulam
    BLOOD, 2014, 124 (21)
  • [35] Analysis of prognostic factors for allogeneic marrow transplantation following BuCy2 in myelodysplastic syndrome.
    Copelan, EA
    Penza, SL
    Elder, PJ
    Ezzone, SA
    Scholl, MD
    Bechtel, TP
    Belt, PS
    Avalos, BR
    BLOOD, 1999, 94 (10) : 661A - 661A
  • [36] Allogeneic hematopoietic stem cell transplantation in adults with myelodysplastic syndrome: Experience of the Argentinean Group of Bone Marrow Transplantation (GATMO)
    Basquiera, Ana L.
    Rivas, Maria M.
    Remaggi, Guillermina
    Klein, Graciela
    Milovic, Vera
    Cecilia Foncuberta, M.
    Saba, Silvia
    Milone, Jorge H.
    Arbelbide, Jorge
    Jaimovich, Gregorio
    Martinez Rolon, Juliana
    Kusminsky, Gustavo
    Garcia, Juan J.
    Prates, Maria V.
    HEMATOLOGY, 2016, 21 (03) : 162 - 169
  • [37] CYCLOSPORIN IN ALLOGENIC BONE-MARROW TRANSPLANTATION
    KLINGEMANN, HG
    STORB, R
    INTERNIST, 1985, 26 (09): : 569 - 574
  • [38] Allogenic bone marrow transplantation in multiple sclerosis
    Jeffery, DR
    Alshami, E
    NEUROLOGY, 1998, 50 (04) : A147 - A147
  • [39] Thalidomide significantly modifies bone marrow microenvironment in myelodysplastic syndrome (MDS) patients.
    Alvi, S
    Borok, RZ
    Shaher, A
    Anthwal, S
    Shaikh, M
    Alvi, I
    Tahir, S
    John, P
    Shetty, V
    Galili, N
    Raza, A
    BLOOD, 2002, 100 (11) : 375A - 375A
  • [40] HUMAN ALLOGENIC BONE-MARROW TRANSPLANTATION
    SYMANN, M
    RODHAIN, J
    HUMBLET, Y
    LOUVAIN MEDICAL, 1977, 96 (03): : 115 - 120
12345